Background illustration for clinical trials search

Paid Clinical Trials Denton

Discover 1,913 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

ERAS® Guidelines Validation of CRS With or Without HIPEC

for
Peritoneal Diseases
Location: Dallas TX, Calgary
Sponsor: Hospices Civils de Lyon

Sex: All

Age: 18+

Code: NCT05185791

Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Dallas TX, Fort Worth TX, Tyler TX, Austin TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

for
Stress Urinary Incontinence, Urinary Incontinence,
Location: Dallas TX, Chicago IL, Durham NC, San Diego CA,
Sponsor: NICHD Pelvic Floor Disorders Network

Sex: Female

Age: 21+

Code: NCT06480227

Recruiting

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Dallas TX, Austin TX, Westwood KS, St Louis MO,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06619561

Phase2, Recruiting

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

for
Radiation Retinopathy, Visual Impairment
Location: Dallas TX, Bellaire TX, Lubbock TX, St Louis MO,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18+

Code: NCT05844982

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

for
Advanced Melanoma
Location: Dallas TX, Houston TX, Westwood KS, Germantown TN,
Sponsor: Replimune, Inc.

Sex: All

Age: 12+

Code: NCT06264180

Phase3, Recruiting

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

for
Relapsed or Refractory T Cell Lymphoma
Location: Dallas TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: Ono Pharmaceutical Co. Ltd

Sex: All

Age: 18+

Code: NCT05079282

Phase1, Recruiting

DBS for Depression

for
Major Depressive Disorder
Location: Dallas TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 22 - 70

Code: NCT03437928

Recruiting

Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head Injuries

for
Head Injuries, Closed
Location: Dallas TX, Houston TX, Toronto
Sponsor: National Center for Research Resources (NCRR)

Sex: All

Age: 0 - 12

Code: NCT00006128

Recruiting

Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population

for
Fatty Liver
Location: Dallas TX
Sponsor: Methodist Health System

Sex: All

Age: 18+

Code: NCT06225193

Recruiting

GammaPod Registry and Quality of Life Nomogram

for
Breast Cancer Female
Location: Dallas TX, Columbia MD, Glen Burnie MD, Bel Air MD
Sponsor: University of Maryland, Baltimore

Sex: Female

Age: 18+

Code: NCT03562273

Recruiting

A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

for
AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia,
Location: Dallas TX, Tyler TX, Houston TX, Denver CO, Gilbert AZ,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT04358393

Phase1, Phase2, Recruiting

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

for
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Dallas TX, Cincinnati OH, Goshen IN, Columbus OH
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04502394

Phase1, Phase2, Recruiting

Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)

for
RCC, Renal Cell Carcinoma
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT05931393

Phase2, Recruiting

Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center

for
Traumatic Injury, PTSD, Posttraumatic Stress Disorder
Location: Dallas TX, Temple TX, Milwaukee WI
Sponsor: Baylor Research Institute

Sex: All

Age: 18 - 70+

Code: NCT06210711

Recruiting

Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

for
PSC
Location: Dallas TX, Indianapolis IN, Rochester MN, Miami FL,
Sponsor: PSC Partners Seeking a Cure

Sex: All

Age: 18 - 70+

Code: NCT06297993

Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: Dallas TX, Tyler TX, Temple TX, Abilene TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase3, Recruiting

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

for
Cystic Fibrosis, Parenthood Status
Location: Dallas TX, Kansas City KS, St Louis MO, Birmingham AL,
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT06296394

Recruiting

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

for
Pulmonary Embolism
Location: Dallas TX, Birmingham AL, Knoxville TN, Tucson AZ,
Sponsor: Innova Vascular, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06041594

Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Fort Worth TX, Kingwood TX, Houston TX, Springdale AR,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase3, Recruiting